Comprehensive molecular investigations in BC patients are necessary to examine if there are other polymorphisms in the TNF-α and TNFR2 genes that could potentially enhance their interaction and whether these polymorphisms are BC-subtype specific. The gene discussed is TNFRSF1B; the disease is breast cancer.